I. INTroducTIoN
The rapidly developing field of neural tissue engineering offers tremendous promise for future therapies to mitigate or reverse effects of disease, aging, or injury in the nervous system. Neural tissue engineering broadly spans a collection of many individual approaches (e.g., biomaterial scaffolds, biological grafts, stem cell therapy) for numerous nervous system applications (e.g., surgical, regenerative, disease treatment, deep brain stimulation). The central theme of this article on neural tissue engineering is the development and implementation of living, 3-D neural cellular based constructs.
ABBrEVIATIoNS
3-D, three dimensional; PNS, peripheral nervous system; CNS, central nervous system; SC, Schwann cell; SEM, scanning electron microscopy; CAP, compound action potentials In these applications, tissue engineered neural constructs consist of several combinations of living neurons distributed throughout neuronal specific matrices/scaffolds created in vitro prior to transplantation in vivo. Specifically, we review the development of living constructs engineered to (1) directly replace damaged or diseased neural tissue, (2) augment the capacity for nervous system regeneration and restore lost function, and (3) facilitate functional nervous system integration with living biohybridized neural-electrical microsystems.
Neural tissue engineering design criteria are based on the unique application, ranging from neuroregenerative to neural interface modalities in vivo. The complexity of these 3-D applications makes it difficult to design and assemble solutions within the living body. In contrast, engineering these 3-D systems in vitro results in a level of control not possible in vivo. Characteristics such as the cellular composition, matrix/scaffold properties, mechanical environment, and exogenous factors may be by design. For instance, matrix gelation behavior, charge gradients, and/or pressure gradients may be exploited to engineer constructs with cells dispersed throughout a 3-D matrix, either in a homogenously (random) or a choreographed fashion (discrete neuronal populations and/or segregating cell types). These systems are also amenable to control of the physical environment of the cells through the application of external forces, which we exploit to drive and control neural cell growth.
This review addresses key design considerations and criteria based on particular studies or applications, specifically engineered constructs for neuroregeneration and biohybridized neural interface microsystems. For neuroregenerative applications, neural constructs may be "pre-engineered" in vitro with controlled neuroanatomical and functional characteristics based on the desired application. In particular, a common feature in many neurological diseases or trauma is the loss of axons, typically long projections connecting populations of neurons or relaying peripheral signals. Axonal regeneration is often insufficient due to long distances to appropriate peripheral targets [1] [2] [3] [4] [5] or the nonpermissive environment of the central nervous system. [6] [7] [8] Overall, living tissue engineered axonal constructs may be a promising strategy to facilitate nervous system repair by directly restoring lost connections or by serving as a scaffold to promote host regeneration by exploiting axonmediated axonal regeneration. Three-dimensional neural tissue engineering technology can also be applied to functionally integrate neural cells with engineered nonbiological components for electrical or electrochemical communication. Such biohybridized neural interface microsystems may be designed for sustained neural-electrical interface with the peripheral nervous system (PNS) or central nervous system (CNS). 9, 10 The concept of "pre-engineering" 3-D tissue engineered constructs in vitro for a particular neurological disease/injury treatment is an extremely valuable approach. While it offers the advantage of experimental control, a clear understanding of design parameters and their influence on cell survival, growth, and functionality is necessary for successful application. Important considerations for future clinical applications of these technologies include adequate survival (e.g., immune tolerance, mass transport) and functionality (e.g., avoidance of aberrant connectivity) to achieve desired functional restoration. Collectively, these observations will present the major challenges as well as the key factors for successfully engineering these constructs.
II. NEurorEgENErATIoN IN VIVo II.A. overview
Neural tissue engineering is continuously applying new solutions for nervous system repair and regeneration. Most strategies individually focus on novel biomaterials, trophic support, or cellular therapies. Pure biomaterial strategies (e.g., acellular scaffolds) are appropriate in many scenarios and are intended to recruit endogenous cells to form new tissue in vivo. 11, 12 While trophic support is important, successful regeneration will be achieved in combination with other strategies. 2, 6, 13, 14 Engineered cells and/or cell-replacement strategies (stem cells in particular) are typically delivered directly to the nervous system (see Ref. 15 for a review). While each individual strategy has shown promise, investigators in the field of neural tissue engineering recognize that it will be a combination of strategies that provides the best solution to nervous tissue repair. 5, 6, 8, 13, [16] [17] [18] [19] Evolving neural tissue engineering technology involves the integration of engineered living tissue constructs to directly replace lost function and/or to facilitate and augment the capacity for host nervous system regeneration. The key attributes of tissue engineered constructs are neural cells (oriented or random), three-dimensionality, and a scaffold support structure. Typically, tissue engineered constructs are completely or partially created in vitro, with final 3-D form sometimes occurring in vivo. Depending on the desired function, the integration with this engineered living tissue may be temporary or permanent, including attenuating degeneration, augmenting endogenous regeneration, or serving as a permanent cell/tissue replacement. Overall, these 3-D neural constructs may be engineered in vitro prior to transplantation in vivo with controlled physical and functional characteristics to combat specific disease or injury conditions.
II.B. Applications
Many forms of nervous system trauma or disease share a common feature of loss of axons, often involving the long projections connecting populations of neurons in the brain and spinal cord or relaying peripheral sensory/motor signals. Accordingly, a common goal in neurorepair and neural tissue engineering is to promote and direct axonal regeneration. Examples of such conditions include physical trauma (e.g., stroke, spinal cord injury), tumor resection (e.g., acoustic neuroma, optic nerve meningioma), and neurodegenerative diseases (e.g., Parkinson's disease, multiple sclerosis). [20] [21] [22] [23] [24] Depending on the circumstances, this axonal loss may occur with or without associated perikaryal death. [25] [26] [27] [28] However, in the CNS, appropriate axonal regeneration does not occur due to a combination of a nonpermissive microenvironment, extraordinary distances to appropriate targets, and the potential for aberrant synaptogenesis (see Refs. 6, 13, 29-31 for reviews). To combat these problems, strategies to coax long-distance, targeted axonal connections are actively being pursued. For example, following injury, strategies involve both enhancing the intrinsic ability of axons to regenerate [32] [33] [34] and modifying extrinsic factors to create a microenvironment more permissive for axonal outgrowth. [35] [36] [37] Biomaterial-based strategies with micro-and nanoscale features are being investigated to promote axonal regeneration. In particular, tubular guidance conduits are being developed to facilitate repair following spinal cord injury [38] [39] [40] [41] or peripheral nerve injury. 5, [42] [43] [44] Engineered nano-and/or microfibers have shown promise by directly or indirectly eliciting robust and longitudinal axonal outgrowth in vitro 42 and in vivo. 45, 46 The addition of anisotropic topology and growth-promoting cues has proven to enhance neurite outgrowth in vitro 47 as well as repair and regeneration in vivo. 48 Moreover, conduits consisting of aligned microchannels have been engineered for the specific purpose of promoting Schwann cell (SC) infiltration and organization, thus facilitating longitudinal axonal regeneration in the PNS. 49 Similarly, nerve guidance channels are also being developed that contain SCs to promote axon growth; however, these cells are typically not organized prior to implantation. 50 For reestablishment of proper connectivity, precise spatial presentation of growth promoting as well as inhibitory signals will be required, as was demonstrated in targeting sensory axon regeneration to synapse at appropriate targets in the spinal cord. 51 In addition, cell transplantation strategies are promising due to the ability to provide trophic support while potentially replacing a range of cell types lost due to trauma or disease. [52] [53] [54] [55] [56] However, seldom do these potential therapies deliver neural cells preformed into a particular architecture capable of recapitulating longer segments of lost neuroanatomy. Despite several promising strategies actively being pursued, the goal of long-distance, targeted reinnervation between discrete nuclei remains elusive. 2, 5, 12 Alternatively, the transplantation of pre-engineered living axonal tracts projecting from differentiated neurons may be an attractive solution to directly reconnect discrete neuronal populations in the central nervous system. Based on prescribed functional characteristics (e.g., neuronal subtype, genetic modification), these living axonal tracts could potentially "wire in" to directly restore lost function, thereby reconnecting previous synaptic partners or creating new circuits around a damaged region. Alternatively, such axonal constructs may promote and guide axonal regeneration by exploiting axon-mediated axonal outgrowth. As such, axonal constructs may provide a living scaffold for directed axonal regeneration, leading to targeted nerve tract reestablishment and synaptic integration with final end targets (e.g., other neuron(s), muscle, sensory organ).
One mechanism by which axonal constructs promote targeted, expeditious regeneration may be axon-mediated axonal outgrowth. Axon-mediated axonal outgrowth has been studied in the context of developmental neurobiology, but the mechanism and potential for this mode of axon outgrowth for regeneration is unknown. Alternatively, the potential for glial-based axonal regenerative guidance has been established. For instance, in peripheral nerve regeneration, the glia, referred to as Schwann cells, are necessary to facilitate axonal regeneration through alignment and the formation of the Bands of Bungner. 57 Recently, the ability of astrocytes to mediate aligned neuritic outgrowth was demonstrated, which required an anisotropic alignment of astrocytic cell bodies and processes. 58 Axon-mediated axonal regeneration may prove to be equally robust. This combination of anisotropic contact guidance and neurotrophic support would provide a labeled pathway for axonal outgrowth, potentially facilitating expeditious, targeted regeneration. However, further understanding of mechanisms driving axon-mediated axonal outgrowth may be useful when applied to tissue engineered constructs designed to promote directed axonal regeneration following injury.
II.c. Tissue Engineered Living Axonal constructs
Here we describe two fundamentally different strategies to create living 3-D neural tissue constructs "pre-engineered" in vitro to recapitulate the neuroanatomy lost due to disease or trauma ( Fig. 1 ). These constructs are designed to serve as neural tissue replacements to recapitulate lost axonal tracts that, upon transplantation, may restore function by direct replacement and/or serving as a scaffold for targeted reconnection. The first strategy consists of long tracts (e.g., several centimeters long) of mechanically engineered living axons encapsulated in 3-D matrices. In this approach, long axonal tracts are generated by a newfound process of "axon stretch growth," the mechanisms and applications of which have recently been described. [59] [60] [61] In a second strategy, tubular microconduits (e.g., 500-µm diameter) with internalized living longitudinally aligned axons were engineered to be delivered into the nervous system in minimally invasive fashion for targeted restoration of axonal tracts.
Axonal constructs engineered via stretch-growth in vitro.
The central feature of these tissue engineered constructs is tracts of living axons created in vitro by the controlled separation of two integrated populations of neurons 60, 62 We have designed and built a series of axon elongation devices for the purpose of creating nerve constructs in vitro. 61, 63 We designed the devices to physically split integrated neuronal cultures into two halves and progressively separate the halves further apart using a microstepper motor system that can operate within a cell culture incubator. Accordingly, bundles of axons that crossed the border between the two halves prior to separation would be progressively elongated (Fig. 2) . We have demonstrated and optimized extreme stretchgrowth of integrated axonal tracts using controlled mechanical tension, and have used various neuronal subtypes including cerebral cortical neurons, neuronal-like cell lines, and dorsal root ganglion neurons. Using this technique we have grown tracts of up to 10 cm in length containing over a million axons. 60 Scanning electron microscopy (SEM) studies of stretch-grown axons showed that the external properties of the rapidly elongating axon bundles appeared healthy and robust, with fascicles of tightly joined axons following an amazingly straight path (Figs. 2d, 2e) . Indeed, stretch-growth of axons is well tolerated, producing a normal appearing cytoskeleton, and retaining the ability to transmit electrophysiological signals. 64 Exploiting this axonal stretch-growth technology, we have recently developed a novel tissue engineering approach to create transplantable living nervous tissue constructs composed of parallel tracts/fascicles of axons spanning two neuronal populations. Prior to transplantation, the stretchgrown axonal tracts were embedded in a proteinaceous matrix and removed from the culture environment en masse. 61, 63 For the application of PNS repair, these engineered nervous tissue constructs consisting of living axonal tracts mimic the uniaxial geometry of axons in the missing nerve segment, and thus may facilitate axonal regeneration (Fig. 3) . Recently, we utilized the resulting 3-D tissue engineered stretch-grown axonal constructs to bridge an excised segment of peripheral nerve in the rat. 65 The axonal constructs were transplanted to bridge an excised segment of sciatic nerve (>1 cm) in the rat and histological analyses were performed at time-points up to 16 weeks post-transplantation to determine graft survival, integration, and host regeneration. We observed tissue engineered axonal constructs with surviving clusters of graft neuronal somata at the proximal and distal extremes of the constructs spanned by long axonal tracts; thus the overall geometry was maintained (Fig. 3) . In addition, we have found comprehensive integration of the transplanted ganglia and axons with the host axons. In particular, throughout the transplanted region, there was an intertwining plexus of host and graft axons, suggesting that the transplanted axons mediated host axonal regeneration across the lesion (Fig. 4) . By 16 weeks post-transplant, extensive myelination of axons was observed throughout the transplant region. Furthermore, graft neurons had extended axons beyond the margins of the transplanted region, penetrating into the host nerve. Notably, these allogenic transplanted neurons/axons survived at least 16 weeks post-implant in the absence of immunosuppression.
The apparent immuno-privilege of our transplanted stretch-grown axonal constructs in the PNS challenges the conventional wisdom of transplantation rejection, leading us to postulate that the pure neuronal phenotype, the long axonal segments, and/ or rapid integration with host axons facilitated survival. Finally, at 16 weeks post-implant, compound action potentials (CAP) were measured across this transplanted nervous tissue bridge in all animals that were repaired using the living nerve construct (no action potentials were elicited in animals that had been transected without repair). These findings demonstrate the promise of living tissue engineered axonal constructs to bridge major nerve lesions and promote host regeneration, potentially by providing axon-mediated axonal outgrowth and guidance. As a next step, these constructs can be grown to be several centimeters long, appropriate for major nerve injuries. Notably, similar tissue engineered constructs consisting of living axonal tracts were successfully applied to repair spinal cord injury. 63 Living axonal microconduits. In a forward-looking application for CNS repair, we are developing microengineered 3-D hydrogel microconduits containing a discrete neuronal population with internalized living axonal tracts extending unidirectionally several millimeters through the interior. 66 These micro-tissue engineered conduits are approximately 500 µm in diameter-roughly three times the average diameter of a human hair-and up to several centimeters in length. The small size enables delivery into the brain or spinal cord via stereotaxic microinjection. Thus, these living axonal microconduits were specialized for the application of reconnecting discrete neuronal populations in the brain or spinal cord to restore function following disease or trauma. In principle, these 3-D engineered microconduits may potentially serve the dual purpose of a neuronal/axonal replacement with pre-engineered cytoarchitecture to directly restore lost connectivity, as well as providing a living labeled pathway to facilitate targeted host regeneration if the source neurons are intact and capable, especially in cases where long-distance axonal regeneration is not feasible. Moreover, living 3-D axonal constructs may provide a regenerative path to bridge nonpermissive and/or inhibitory barriers such as the glial scar which commonly forms following trauma.
The overall strategy is to create neural tissue engineering constructs "pre-engineered" in vitro to contain living aligned axonal tracts, thus mimicking a key feature lost to disease or trauma. Moreover, living axonal conduits may be unidirectional or bidirectional (Fig. 1) , and may employ alternate geometries to enable some degree of curvature. These axonal conduits may then be contained within nerve guidance channels to protect the axonal tracts during and after implantation. The key to applying this strategy is the ability to generate long (up to several centimeters) living axonal tracts, and the capability to create a 3-D architecture to provide support prior to delivery in vivo. Moreover, the microversions of this technology were developed specifically to be delivered in a minimally invasive fashion without damaging the transplanted neurons and the axonal architecture. Overall, these living axonal constructs exploit tailored physical properties, anisotropy, and contact guidance to promote expeditious and targeted reinnervation. These engineered transplantable living axonal constructs may significantly add to the repertoire of tissue engineered strategies for nervous system repair. By recapitulating the neuroanatomy of tissue lost due to trauma or disease, these axonal tracts may serve as functional replacements or a labeled pathway to guide host axonal regeneration, potentially exploiting axon-mediated axonal regeneration.
However, there are key challenges related to survival and functionality that require further study. Acute transplant survival will be influenced by mass transport, after which short-and long-term immunological responses will be critical. It is noteworthy that if the goal of transplanted axonal constructs is to provide a living labeled pathway for host axonal regeneration, then the graft may need to survive for tem while preserving the totality of the processing power of the brain and spinal cord.
Current neural-electrical interface platforms have been developed for extracellular monitoring and modulation of neuronal population activity over weeks, months, or even years. For interfacing with the nervous system of living organisms, arrays of sharp penetrating electrodes have traditionally been used to record neuronal population signaling. These systems have classically involved rigid metal and/or only the time it takes the host axons to grow across. In addition, in cases where transplanted neurons/ axons assume a permanent functional role within the host nervous system, issues related to proper connectivity, plasticity, and avoidance of deleterious connectivity will be paramount.
III. BIohyBrId NEurAL INTErFAcE MIcroSySTEMS IN VIVo III.A. overview
Each year in the U.S., several hundred thousand people suffer debilitating injuries that ultimately result in the loss of limb function. These populations would be greatly served by a new generation of prosthetic devices. The ideal neuroprosthesis would be a functional facsimile of the amputated limb, and facilitate continuous bidirectional communication between the CNS and the external environment. Currently, the vast majority of efforts in this area focus exclusively on the reestablishment of motor control, relying on visual feedback to guide the movement of the prosthesis. However, in order to achieve truly "normal" interaction with the surroundings, tactile feedback is vital. Additionally, from a clinical and rehabilitation standpoint, it is important to have an architecture that minimizes surgical complexity and recovery time, provides a hospitable environment for nerve survival, and lends itself to rapid learning.
In the drive towards a fully functional neuroprosthesis, efforts are being made in the fields of both invasive and noninvasive neural interfaces, with only moderate success thus far. Although these techniques are able to restore some function, they remain cumbersome, often involve complex surgical procedures, and are limited in the versatility and complexity of functions that they can perform. [67] [68] [69] [70] [71] [72] [73] Moreover, for these approaches it is challenging to enable afferent signaling of sensory stimuli directly to the nervous system. It is evident that an urgent need exists for a versatile neural interface that can enable bidirectional communication with prosthetic devices, while minimizing surgical complexity and time for recovery. However, there is currently no approach that directly innervates the nervous sys- silicon electrodes. However, there is typically signal attenuation or degradation over time, which may be attributed to a general foreign-body and inflammatory response resulting in localized scar tissue and a decrease in the neuronal density in the vicinity of an electrode. 74, 75 Thus, strategies to mitigate the detrimental response to chronic electrode placement are actively being pursued. For instance, there has been recent interest in developing more flexible electrodes (Fig. 5) to mitigate detrimental effects due to the mismatch of mechanical properties. 76 Future approaches might combine neural tissue engineering with electrical interface technology to develop a strategy to coax axonal or dendritic growth from the host to the interface hardware for functional integration. The resulting biohybridized neural interface microsystems would serve as tissue engineered neural-electrical relays for improved neural integration and chronic performance. Also, in specific cases, this technique may provide a replacement end target for nervous system integration in cases where the original target is missing or irreparably damaged. These techniques may be useful for chronic integration with the CNS (e.g., retinal prosthesis). However, we focus on applying these biohybridized microsystems for integration with the PNS (e.g., to ultimately drive a robotic prosthetic limb), which we view as the "back door" into the brain.
III.B. Biohybrid Interface Microsystems for Functional Integration with Peripheral Nerve
Biohybrid neural interface microsystems have tremendous potential as constructs to augment in vivo neuroregenerative capabilities while enabling a living biohybridized interface with the nervous system. The key concept underpinning this biohybridized microsystem is to enable robust host axonal integration, thus providing the infrastructure to acquire motor output and enabling sensory input. In this particular case, it is surgically and computationally advantageous for the neural interface to occur with the PNS to avoid implanting electrodes into the otherwise noninjured brain or spinal cord, while simultaneously being at the point of final brain output [receiving motor command signal(s)
for actuation] and primary sensory input (sensory and proprioceptive feedback). However, peripheral nerve axons require a living target for innervation, hence the use of our biohybridized living tissue engineered relays. Because host integration may occur with the biological component of this biohybrid platform, this may exploit a more natural interface. In theory, this approach leverages the exquisite processing capacity of the CNS rather than straining to decipher it. Also, this strategy may circumvent the issue of scar tissue formation in the brain that is thought to be primarily responsible for the relatively short windows of operation for conventional electrodes. Thus, this approach may be promising to advance prosthetic control by exploiting a more natural interface, potentially enabling substantial complexity of the command signal while providing a vehicle for proprioceptive and other sensory feedback.
Our current efforts are to develop and implement nervous tissue interface platforms consisting of arrays of mechanically compliant electrodes embedded in living 3-D neural cellular constructs. Thus, our goal is to engineer 3-D neural cellular constructs, 10, 61, 77 with the added element of electrical functionalization via construct formation around a conductive backbone. An additional advantage of these neurobiologically active living tissue engineered neural relays is that a stable electrical interface may be formed in vitro prior to implementation in vivo. Host integration may occur with the biological component of this biohybrid platform, thus potentially leading host axons to electrically active components. 10, 77 Forming stable interfaces in vitro prior to in vivo integration may also mitigate several of the factors believed to contribute to performance degradation of chronically implanted electrodes. 78 
Neural-Electrical Relays using Electrically Active Fiber Arrays
In one strategy, we are engineering living tissue engineered neural-electrical relays through the development of custom-built, encapsulated nervous tissue interface platforms consisting of arrays of mechanically compliant microelectrodes embedded in living 3-D neural cellular constructs. Such technology may serve as functional components for a biohybrid neural interface microsystem to be used as quantitative neurophysiological platforms or as neurobiologically active electrical relays. Electrically conducting polymer fibers are attractive substrates for sustained functional interfaces with neuronal populations due to their relative flexibility (compared to metal or silicon), modifiable geometry and chemistry, and controlled electroconductive properties. 79, 80 Polyaniline-based electrically conducting polymer fibers are attractive substrates for sustained functional interfaces with neurons due to their flexibility, tailored geometry, and controlled electroconductive properties. To date, we have addressed the neurobiological considerations of utilizing small diameter (<400 µm) fibers consisting of a blend of electrically conductive polymers as the backbone of encapsulated tissue engineered neural-electrical relays. 9 We devised new approaches to promote survival, adhesion, and neurite outgrowth of primary dorsal root ganglion neurons on the fibers. We attained a greater than tenfold increase in the density of viable neurons on fiber surfaces, to approximately 700 neurons/mm 2 , by manipulating surrounding surface charges to bias settling neuronal suspensions towards fibers coated with cell-adhesive ligands (Fig. 6 ). This stark increase in neuronal density resulted in robust neuritic extension and network formation directly along the fibers. Additionally, we encapsulated these neuronal networks on fibers using agarose to form a protective barrier while potentially facilitating network stability. Following encapsulation, the neuronal networks maintained integrity, high viability (>85%), and intimate adhesion to PA-PP fibers (Fig. 7) . These efforts accomplished key prerequisites for the establishment of functional electrical interfaces with neuronal populations using small-diameter electrically active fibers, including high-density neuronal adhesion and neuritic network development directly on fiber surfaces.
Neural-Electrical Relays with StretchGrown Axons
We have designed and optimized techniques to adapt our stretch-grown axonal constructs for stable use with flexible multielectrode array technology. 10 Both stretch-grown and non-stretch-grown cultures were maintained over several days in vitro with one end pre-adhered to a multielectrode array. Then, the neuronal/axonal cultures were encapsulated and removed from the culture environment en masse. Following insertion into a surgical tube, the constructs were attached to the proximal stump of a transected peripheral nerve in the rat. Over weeks post-implantation, the proximal nerve remained in intimate contact with our electrode array within our construct. Moreover, we observed evidence of host revascularization into the constructs. We utilized standard tissue processing techniques and immunohistochemistry to assess host regeneration using antibodies for the axonal protein tau. Remarkably, we found host axons had regenerated within the constructs and were within tens of microns of the implanted electrode array (Fig. 5) . These results provide strong evidence for the feasibility of this approach to form a neural-electrical interface with spared segments of the PNS following trauma.
Thus, we have made substantial advancements in implementing these living constructs in 3-D tissue engineered neural-electrical relays incorporating compliant electrode array technology. 10 These techniques are complimentary to our methodology to grow high-density neuronal networks directly on conductive microfibers with subsequent hydrogel encapsulation in preparation for in vivo transplantation. 9 This technology may have dual integrative ability: providing a surrogate end target in cases where the original target is irreparably damaged or lost and/or promoting axon growth to integrate with the electrodes by providing a living scaffold. Moving forward, a key challenge will be the demonstration of synaptic integration of the regenerating sensory and motor peripheral axons with our biohybridized microsystems, which may be necessary for chronic integration and function.
IV. SuMMAry ANd chALLENgES
Research in neural tissue engineering and biohybrid neural interface microsystems is driven by the development of cutting-edge regenerative medicine and interface technology. A promising approach is Neuronal encapsulation on microfibers. For future transplantation, removal from culture while maintaining neuronal network integrity and viability is necessary. In order to demonstrate this using hydrogel encapsulation, neurons were plated on collagen-coated conductive polymer microfibers and, at 6-9 days in vitro, encapsulated using 0.5-1.0% agarose. to utilize tissue engineered constructs consisting of living neural cells within 3-D matrices, which may enhance regeneration or neural interface following neural injury or disease. Prior to in vivo delivery, these constructs may be pre-engineered in vitro with defined functional, geometric, and neuroanatomical features based on application, and may possess anisotropic features or a homogenous cell distribution, with or without electrical interface technology.
For neuroregeneration, we have developed tissue engineered constructs to mitigate axonal loss, a prominent feature following trauma or disease in the nervous system. Our overall strategy is to create 3-D living axonal tracts that are designed to recapitulate lost neuroanatomy (Fig. 8) . In one case, we mechanically engineer constructs consisting of long axonal tracts-up to 10 cm in length-which we have applied successfully to facilitate neuroregeneration following severe peripheral nerve or spinal cord injury. 63, 65 This technique is based on the ability of integrated axons to respond to continuous mechanical tension by exhibiting stretchgrowth, which produces progressively longer axons that gradually coalesce into large nerve tracts. 59, 60, 62 In another approach, we engineered 3-D tubular microconduits with internalized longitudinally aligned, living axonal tracts. Due to their micronscale size, these microconduits may be delivered via injection in a minimally invasive fashion. In future applications, these 3-D microconduits may be precisely delivered to potentially reconnect neuronal populations following axonal loss. In addition, we have observed substantial axonal growth longitudinally along conductive microfibers, creating another technique for directed axonal extension. Based on these techniques and perhaps others, the transplantation of living axons pre-engineered to recapitulate lost axonal tracts may restore function by directly replacing lost connections or by serving as a scaffold to promote targeted host regeneration. For the latter purpose, the axonal constructs may create "regenerative highways" for targeted nerve tract restoration by exploiting axon-mediated axon regeneration.
Our other application of neural tissue engineering technology is to biohybridize neuralelectrical relays for functional integration with the host nervous system. This biohybridization of neural interface technology through a blending with neural tissue engineering techniques may directly promote host axonal integration, and therefore chronic communication. Accordingly, we are developing biohybridized neural interface microsystems consisting of living tissue engineered neural cellular constructs encapsulated within electrically active microarrays. These biohybridized microsystems may augment neuroregenerative capabilities in vivo and may be efficacious in improving axonal integration due to biologically mediated pathfinding. In addition, in the case of loss of limb, these biohybridized microsystems may serve as a surrogate end target, and thus provide a bidirectional electrically active neural interface to relay motor commands from and sensory signals to the spinal cord and brain. The long-term goal of these efforts is to create a robust, direct interface with the nervous system to drive sophisticated prosthetic devices for sustained man-machine interface. There are tremendous challenges for the in vivo survival and efficacy of tissue engineered neural constructs and/or biohybrid interface platforms. In addition to functional characteristics, issues pertaining to inflammation/immunogenicity and mass transport are paramount. Some degree of construct optimization may occur in vitro; however, challenges regarding survival and function following in vivo delivery will be inevitable. As strategies are developed to mitigate these challenges, the ability to engineer these nerve constructs with tailored cellular, anatomical, geometric, and functional characteristics will be extremely beneficial. With regard to immune tolerance, it may be possible to modulate construct attributes to modify the immunogenicity of the transplanted cells. This issue will be influenced by the goal of the construct. For instance, axonal conduits serving as regenerative scaffolds need remain only until host axons have reinnervated a target. Conversely, if the goal is to permanently replace lost connections, then chronic immune tolerance is required. We have found surprising survival, and hence im- mune tolerance, of neuron-only constructs, which may be due to a low immunogenicity in these cells or rapid integration with the host nervous system. Other strategies such as cell/genetic engineering may further decrease the immunogenicity without compromising function. Also, attenuation of the foreign-body reaction to any biomaterial/microelectrodes may require systemic or local delivery of anti-inflammatory agents. In addition, unintended functionality will also need to be evaluated to avoid aberrant connectivity and thus achieve desired functional restoration.
Advances in neuroregeneration could profoundly impact millions of patients suffering from brain injuries, spinal cord injuries, or neurodegenerative disorders. Here, neural tissue engineering offers tremendous therapeutic promise, and thus tissue engineered constructs to restore lost neurological function are aggressively being pursued. In addition, chronic neuroprosthetic interfaces providing seamless motor and sensory control would greatly improve the quality of life of thousands dealing with loss of limb amongst other debilitating peripheral nerve injuries. Moreover, the biohybridization of neural interface technology through a blending with neural tissue engineering techniques may promote functional integration with the host nervous system. In these areas, the successful application involves the integration of engineered living tissue with the host nervous system to mitigate deficits, directly restore lost function, or to augment the capacity for nervous system regeneration.
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